LeMaitre Vascular: Beware Valuation Reset

04:19pm, Friday, 27'th Mar 2020
LeMaitre Vascular has a strong product line that will see demand in all economic conditions. In context of the prior bull market and as a result of its competit
Equities research analysts expect LeMaitre Vascular Inc (NASDAQ:LMAT) to announce sales of $31.18 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for LeM
Algert Global LLC lowered its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 27.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The i
Silk Road Medical went public in early 2019. The firm sells carotid artery treatment devices to prevent stroke. SILK has grown revenue remarkably and expects fu
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Citigroup Inc. reduced its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 11.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 9,131 shares of the medical instruments supp
Great West Life Assurance Co. Can purchased a new position in LeMaitre Vascular Inc (NASDAQ:LMAT) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Prudential Financial Inc. grew its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 4.7% in the fourth quarter, Holdings Channel reports. The firm owned 26,997 shares of the medical instruments supp
Wall Street brokerages predict that LeMaitre Vascular Inc (NASDAQ:LMAT) will announce earnings per share (EPS) of $0.17 for the current fiscal quarter, Zacks Investment Research reports. Three analyst
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Stocks That Hit 52-Week Lows On Monday

02:34pm, Monday, 23'rd Mar 2020
On Monday morning, 720 companies hit new 52-week lows. Noteworthy Mentions: The largest company by market cap to set a new 52-week low was Alphabet (NASDAQ: GOOGL)...
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
Shares of LeMaitre Vascular Inc (NASDAQ:LMAT) have been assigned an average rating of “Buy” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Four res
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by research analysts at Sidoti from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, Marketbeat
How far off is LeMaitre Vascular, Inc. (NASDAQ:LMAT) from its intrinsic value? Using the most recent financial data...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE